Acquired hemophilia A (AHA) is a rare bleeding disorder caused by the spontaneous development of neutralizing autoantibodies (inhibitors) directed against the endogenous coagulation factor VIII (FVIII). This evidence concerns the gene F8 and autoimmune hemolytic anemia.